Back to mobile site

Amneal Pharmaceuticals to acquire Kashiv BioSciences in biosimilar deal

April 22, 2026 6:17 AM EDT Send to a Friend
Amneal Pharmaceuticals Inc. (NASDAQ: AMRX) has entered into a definitive agreement to acquire Kashiv BioSciences LLC, according to a press ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login